Position in BDSX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,307,268
+$298,054 QoQ
Shares Held
57,972
-16.7% QoQ
Ownership
0.549%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 44 holders
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in BDSX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $173,824,007 across 15 Diagnostics & Research names. BDSX ranks #14 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
123,380 | $64,952,167 | |
| 2 | TWST |
Twist Bioscience Corp
|
255,271 | $26,262,280 | |
| 3 | GH |
Guardant Health, Inc.
|
159,869 | $23,985,146 | |
| 4 | A |
Agilent Technologies, Inc.
|
76,048 | $10,101,455 | |
| 5 | NTRA |
Natera, Inc.
|
35,374 | $9,602,272 | |
| 6 | ICLR |
Icon PLC
|
48,182 | $8,369,695 | |
| 7 | PSNL |
Personalis, Inc.
|
600,216 | $8,042,894 | |
| 8 | NEO |
Neogenomics Inc
|
435,783 | $6,358,073 |
All Filings in BDSX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,307,268 | 57,972 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,009,214 | 69,601 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $187,285 | 27,542 | Shares | Sole | 2026-02-17 | |
| 2021-09-30 | $155,004 | 18,857 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $156,855 | 11,874 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||